Create Account | Sign In: Author or Forum

 
 
News  |  Journals  |  Conferences  |  Blogs  |  Articles  |  Forums  |  Twitter    
 

 Headlines:

 

Category: Cardiology | Gastroenterology | Internal Medicine | Surgery | Journal

Back to Journal Articles

PCI Safe and Feasible in End-Stage Liver Disease

Last Updated: July 04, 2011.

 

Percutaneous coronary intervention for coronary artery disease safe for liver transplant candidates

Share |

Comments: (0)

Tell-a-Friend

 

  Related
 
Percutaneous coronary intervention for coronary artery disease is safe and feasible for liver transplant candidates with end-stage liver disease, according to a study published in the July issue of Liver Transplantation.

MONDAY, July 4 (HealthDay News) -- Percutaneous coronary intervention (PCI) for coronary artery disease (CAD) is safe and feasible for liver transplant candidates with end-stage liver disease (ESLD), according to a study published in the July issue of Liver Transplantation.

Babak Azarbal, M.D., from the Cedars-Sinai Medical Center in Los Angeles, and colleagues investigated the feasibility and safety of PCI in liver transplant candidates. A total of 16 participants with ESLD hemodynamically significant CAD who were otherwise satisfactory candidates for liver transplantation underwent PCI; 15 with bare-metal stents, and one with only balloon angioplasty. The procedural success rates, rates of mortality and myocardial infarction, and bleeding outcomes were assessed.

The investigators found that the median diameter stenosis in each lesion was 80 percent, and the the median platelet count was 68 x 109/L. A total of 94 percent of the patients had successful PCI. Post-stenting, one patient had suboptimal residual stenosis of 50 percent. There were no deaths, in-hospital or at 30 days, no myocardial infarctions, and no hematoma formations. Two patients required transfusions: one a unit of platelets and the other a unit of packed red blood cells. At one month post-PCI, all patients remained clinically stable. Nine of the 16 patients listed for liver transplantation, and three of them underwent the transplant procedure.

"We have demonstrated the safety and feasibility of performing PCI in a small cohort of patients with ESLD and hemodynamically significant CAD, the majority of whom had significant thrombocytopenia," the authors write.

Abstract
Full Text (subscription or payment may be required)

Copyright © 2011 HealthDay. All rights reserved.


Previous: Lazanda Approved for Cancer Pain Next: Memory Blackouts Predictive of Alcohol-Related Injury

Reader comments on this article are listed below. Review our comments policy.


Submit your opinion:

Name:

Email:

Location:

URL:

Remember my personal information

Notify me of follow-up comments?

advertisement.gif (61x7 -- 0 bytes)
 

Are you a Doctor, Pharmacist, PA or a Nurse?

Join the Doctors Lounge online medical community

  • Editorial activities: Publish, peer review, edit online articles.

  • Ask a Doctor Teams: Respond to patient questions and discuss challenging presentations with other members.

Doctors Lounge Membership Application

 
     

 advertisement.gif (61x7 -- 0 bytes)

 

 

Useful Sites
MediLexicon
  Tools & Services: Follow DoctorsLounge on Twitter Follow us on Twitter | RSS News | Newsletter | Contact us
Copyright © 2001-2013
Doctors Lounge.
All rights reserved.

Medical Reference:
Diseases | Symptoms
Drugs | Labs | Procedures
Software | Tutorials

Advertising
Links | Humor
Forum Archive
CME | Conferences

Privacy Statement
Terms & Conditions
Editorial Board
About us | Email

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.